EO14398; comprehensive and rapid response for niaid research programs

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N93021D00035
Awardee
Awarding agency
Task orders
7 $203,371,638 obligated

Award facts

Opportunity
Combined order value
  • $203,371,638 Current, with exercised options
  • $384,203,595 Potential, with all options
Last date to order 74% complete
IDV ceiling 37% used
$545,452,906.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 29 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to PPD Development LP on September 1, 2021, with a ceiling of $545.5 million for comprehensive and rapid response capabilities supporting NIAID research programs through August 31, 2028.

The originating solicitation, posted in June 2020, sought a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics, bioinformatics, computational biology, biostatistics, storage, regulatory and quality assurance services, and basic and mechanistic research. The solicitation was partially set aside for small businesses and covered NAICS codes 541715 and PSC codes R425.

Performance is conducted in multiple locations, including Cape Fear, North Carolina and Bethesda, Maryland, supporting NIAID's Division of Clinical Research, Division of Intramural Research, and Vaccine Research Center.

Task orders issued under this IDIQ include a $186.4 million delivery order for NIAID Clinical Site Monitoring services through January 31, 2031; a $75.2 million order for HIV and infectious disease clinical research support services through August 14, 2031; a $64 million order for completion of the ACTIV-2 COVID-19 study (completed August 31, 2025); a $34.6 million order for ACTIV-2 clinical trial management support (completed November 5, 2022); a $21.6 million order for Division of AIDS monitoring services supporting the Phase III PHOENIX study through December 14, 2028, awarded December 15, 2025; and smaller orders including $2.33 million for the CHOICE study and $2,000 for research support services.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award Comprehensive and rapid response for niaid research programs $0

Quick answers

Who was awarded contract 75N93021D00035?

75N93021D00035 was awarded to PPD Development LP by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2021.

How much is contract 75N93021D00035 worth?

Orders under 75N93021D00035 have obligated $203,371,638. Their combined potential value, with all options, is $384,203,595. 75N93021D00035's own ceiling is $545,452,906.

How many orders have been placed under contract 75N93021D00035?

7 orders have been placed under 75N93021D00035, the latest on December 15, 2025.

Who can order from contract 75N93021D00035?

75N93021D00035 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93021D00035 competed?

The extent of competition for 75N93021D00035 was full and open competition. The government received 29 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV